Medicalisation, smoking and e-cigarettes: evidence and implications

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Tobacco Control

• Publication date

  2016-11-30

• Fields of study

  Medicine, Sociology

• Identifiers
  DOI 10.1136/tobaccocontrol-2016-053348PMID 27903957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tobacco Use in Canada : Patterns and Trends Special Supplement : E-cigarettes in Canada

  2017cited by this paper
• Quitting Smoking Among Adults - United States, 2000-2015.

  2017cited by this paper
• Long-term e-cigarette use and smoking cessation: a longitudinal study with US population

  2016cited by this paper
• Electronic cigarettes and smoking cessation in England

  2016cited by this paper
• Smoking, Not COPD, as the Disease.

  2016cited by this paper
• Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends

  2016cited by this paper
• The Past, Present, and Future of Nicotine Addiction Therapy.

  2016cited by this paper
• New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

  2016cited by this paper
• Cigarette prohibition and the need for more prior testing of the WHO TobReg's global nicotine-reduction strategy

  2016cited by this paper
• The case for the WHO Advisory Note, Global Nicotine Reduction Strategy

  2016cited by this paper
• Paying more attention to the ‘elephant in the room’

  2016cited by this paper
• Correlates of Adherence to Varenicline Among HIV+ Smokers.

  2015cited by this paper
• Why Don’t Smokers Want Help to Quit? A Qualitative Study of Smokers’ Attitudes towards Assisted vs. Unassisted Quitting

  2015cited by this paper
• Smokers’ and ex-smokers’ understanding of electronic cigarettes: a qualitative study

  2015cited by this paper
• How the Brain Disease Paradigm Remoralizes Addictive Behaviour

  2015cited by this paper
• Electronic Nicotine Delivery System

  2015cited by this paper
• The Benzodiazepine–Dementia Disorders Link: Current State of Knowledge

  2015cited by this paper
• Working Memory-Related Neural Activity Predicts Future Smoking Relapse

  2015cited by this paper
• Vapers' perspectives on electronic cigarette regulation in Australia.

  2015cited by this paper
• Nicorette reborn? E-cigarettes in light of the history of nicotine replacement technology.

  2015cited by this paper
• It's time to change the default for tobacco treatment.

  2015cited by this paper
• Why do smokers try to quit without medication or counselling? A qualitative study with ex-smokers

  2015cited by this paper
• Increased Functional Connectivity in an Insula-Based Network is Associated with Improved Smoking Cessation Outcomes

  2015cited by this paper
• Politics, profit, and psychiatric diagnosis: a case study of tobacco use disorder.

  2014cited by this paper
• Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete?

  2014cited by this paper
• The renormalization of smoking? E-cigarettes and the tobacco "endgame".

  2014cited by this paper
• Supporting smoking cessation

  2014cited by this paper
• Smoking Motives, Quitting Motives, and Opinions About Smoking Cessation Support Among Expectant or New Fathers

  2013cited by this paper
• The forgotten smoker: a qualitative study of attitudes towards smoking, quitting, and tobacco control policies among continuing smokers

  2013cited by this paper
• Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study.

  2013cited by this paper
• Understanding smokers' motivations to use evidence-based smoking cessation aids.

  2013cited by this paper
• Biogenetic explanations and stigma: a meta-analytic review of associations among laypeople.

  2013cited by this paper
• Harm reduction and the medicalisation of tobacco use.

  2013cited by this paper
• Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews.

  2013cited by this paper
• Electronic nicotine delivery systems: international tobacco control four-country survey.

  2013cited by this paper
• Improving smoking cessation approaches at the individual level

  2012cited by this paper
• Nicotine receptor partial agonists for smoking cessation

  2012cited by this paper
• What are the public policy implications of a neurobiological view of addiction?

  2012cited by this paper
• Supporting smoking cessation: a guide for health professionals.

  2012cited by this paper
• Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades?

  2012cited by this paper
• Quitting Smoking Among Adults — United States, 2001–2010

  2012cited by this paper
• Nicotine control: E-cigarettes, smoking and addiction.

  2012cited by this paper
• 'The smoking toolkit study': a national study of smoking and smoking cessation in England

  2011cited by this paper
• Quitting smoking among adults--United States, 2001-2010.

  2011cited by this paper
• Nicotine receptor partial agonists for smoking cessation.

  2011cited by this paper
• Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.

  2011cited by this paper
• Framing Nicotine Addiction as a "Disease of the Brain": Social and Ethical Consequences.

  2011cited by this paper
• Australian smokers increasingly use help to quit, but number of attempts remains stable: findings from the International Tobacco Control Study 2002–09

  2011cited by this paper
• Repetitive Transcranial Magnetic Stimulation of the Superior Frontal Gyrus Modulates Craving for Cigarettes

  2011cited by this paper
• The Global Research Neglect of Unassisted Smoking Cessation: Causes and Consequences

  2010cited by this paper
• Enabling access to new WHO essential medicines: the case for nicotine replacement therapies

  2010cited by this paper
• "A disease like any other"? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence.

  2010cited by this paper
• Sex work and the 2010 FIFA World Cup: time for public health imperatives to prevail

  2010cited by this paper
• 'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction.

  2010cited by this paper
• Smokers' beliefs about the inability to stop smoking.

  2009cited by this paper
• In defence of helping people to stop smoking.

  2009cited by this paper
• Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption.

  2009cited by this paper
• Beliefs and attitudes about bupropion: implications for medication adherence and smoking cessation treatment.

  2009cited by this paper
• Nicotine replacement therapy for smoking cessation.

  2008cited by this paper
• Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies.

  2008cited by this paper
• Treating Tobacco Use and Dependence: 2008 Update

  2008cited by this paper
• Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance.

  2008cited by this paper
• The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis.

  2007cited by this paper
• Antidepressants for smoking cessation.

  2007cited by this paper
• Challenging the imperative of health? Smoking and justifications of risk-taking

  2006cited by this paper
• Attitudes and knowledge about nicotine and nicotine replacement therapy.

  2006cited by this paper
• The shifting engines of medicalization.

  2005cited by this paper
• Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.

  2005cited by this paper
• Neurobiology of addiction: treatment and public policy ramifications

  2005cited by this paper
• Are smokers adequately informed about the health risks of smoking and medicinal nicotine?

  2004cited by this paper
• Drug addiction: the neurobiology of behaviour gone awry

  2004cited by this paper
• Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them?

  2004cited by this paper
• Economics of smoking cessation

  2004cited by this paper
• Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour.

  2004cited by this paper
• Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine

  2003cited by this paper
• 'I came back here and started smoking again': perceptions and experiences of quitting among disadvantaged smokers.

  2003cited by this paper
• WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty

  2003cited by this paper
• What's Wrong With Addiction?

  2002cited by this paper
• Before the Surgeon-General’s Report: Public Discourse in Australia Over Tobacco Addiction to 1964

  1998cited by this paper
• Slaying the Dragon: The History of Addiction Treatment and Recovery in America

  1998cited by this paper
• Two Tales of Addiction; Opium and Nicotine

  1997cited by this paper
• Addiction is a brain disease, and it matters.

  1997cited by this paper
• Deviance and Medicalization: From Badness to Sickness

  1996cited by this paper
• Deviance and Medicalization: From Badness to Sickness

  1992cited by this paper
• Smoking and smoking cessation.

  1990cited by this paper
• Medicine as an institution of social control.

  1972cited by this paper
• Medicine as an Institution of Social Control

  1972cited by this paper

• Awareness of and support for banning e-cigarettes and heated tobacco products among Mexicans who smoke

  2025cites this paper
• Evaluating the implementation of a prescription only regulatory model for nicotine vaping products: A qualitative study on the experiences and views of healthcare professionals.

  2024cites this paper
• Pharmacist-only supply of nicotine vaping products: proposing an alternative regulatory model for Australia

  2024cites this paper
• Attitudes and influencing factors associated with smoking cessation: An online cross-sectional survey in China

  2023cites this paper
• The Australia Smoking and Vaping Model: The Potential Impact of Increasing Access to Nicotine Vaping Products

  2022cites this paper
• Inequalities in cessation and critique of possible contributing factors: Taking stock of a perseveration with current treatment approaches, uptake of promising treatments, and limited upscaling of interventions with positive equity impact.

  2020cites this paper
• Do Neurobiological Understandings of Smoking Influence Quitting Self-Efficacy or Treatment Intentions?

  2018cites this paper
• E-Cigarettes: Implications for Health Promotion in the Asian Pacific Region

  2018cites this paper
• Vape shops: who uses them and what do they do?

  2018cites this paper
• Vape Club: Exploring Non-Profit Regulatory Models for the Supply of Vaporised Nicotine Products

  2018cites this paper
• Smokers’ Understandings of Addiction to Nicotine and Tobacco: A Systematic Review and Interpretive Synthesis of Quantitative and Qualitative Research

  2018cites this paper
• Is it the nicotine? Australian smokers’ accounts of nicotine addiction

  2017cites this paper
• A typology of vaping: Identifying differing beliefs, motivations for use, identity and political interest amongst e-cigarette users.

  2017cites this paper
• Vaporised nicotine and tobacco harm reduction for addressing smoking among people living with HIV: A cross-sectional survey of Australian HIV health practitioners' attitudes.

  2017cites this paper